Literature DB >> 3311097

Total body electrolyte composition in patients with heart failure: a comparison with normal subjects and patients with untreated hypertension.

J G Cleland1, H J Dargie, I Robertson, J I Robertson, B W East.   

Abstract

Total body elemental composition was measured in 40 patients with well documented heart failure who were oedema-free on digoxin and diuretics. The results were compared with values for 20 patients with untreated essential hypertension matched for height, weight, age, and sex. Total body potassium alone was also measured in 20 normal subjects also matched for anthropomorphic measurements. Patients with hypertension had a very similar total body potassium content to that of normal subjects, but patients with heart failure had significantly reduced total body potassium. This could not be explained by muscle wasting because total body nitrogen, largely present in muscle tissue, was well maintained. When total body potassium was expressed as a ratio of potassium to nitrogen mass a consistent depletion of potassium was revealed in the group with heart failure. Potassium depletion was poorly related to diuretic dose, severity of heart failure, age, or renal function. Activation of the renin-angiotensin-aldosterone system was, however, related to hypokalaemia and potassium depletion. Such patients also had significantly lower concentrations of serum sodium and blood pressure. Serum potassium was related directly to total body potassium. Despite the absence of clinically apparent oedema total body chlorine was not consistently increased in heart failure, but the calculated extracellular fluid volume remained expanded in the heart failure group. Total body sodium was significantly increased in patients with heart failure, but less than half of this increase could be accounted for by extracellular fluid volume expansion. Potassium depletion in heart failure may account in part for the high frequency of arrhythmias and sudden death in this condition.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3311097      PMCID: PMC1216442          DOI: 10.1136/hrt.58.3.230

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  45 in total

1.  Serum-potassium levels as an index of body content.

Authors:  C T FLEAR; W T COOKE; A QUINTON
Journal:  Lancet       Date:  1957-03-02       Impact factor: 79.321

2.  Equations for the prediction of normal values for exchangeable sodium, exchangeable potassium, extracellular fluid volume, and total body water.

Authors:  F Skrabal; R N Arnot; G F Joplin
Journal:  Br Med J       Date:  1973-04-07

3.  Body-fluid volume in low-renin hypertension.

Authors:  M A Schalekamp; M Lebel; D G Beevers; R Fraser; G Kolsters; W H Birkenhäger
Journal:  Lancet       Date:  1974-08-10       Impact factor: 79.321

4.  Use of amiloride as a potassium conserving agent in severe cardiac disease.

Authors:  C Davidson; I M Gillebrand
Journal:  Br Heart J       Date:  1973-04

5.  A comparison of double-isotope derivative and radioimmunological estimation of plasma aldosterone concentration in man.

Authors:  R Fraser; S Guest; J Young
Journal:  Clin Sci Mol Med       Date:  1973-09

6.  Discrepancies between whole-body potassium content and exchangeable potassium.

Authors:  I Surveyor; D Hughes
Journal:  J Lab Clin Med       Date:  1968-03

7.  Renin relationships in congestive cardiac failure, treated and untreated.

Authors:  J J Brown; D L Davies; V W Johnson; A F Lever; J I Robertson
Journal:  Am Heart J       Date:  1970-09       Impact factor: 4.749

8.  The relation of total body potassium to height, weight, and age in normal adults.

Authors:  K Boddy; P C King; R Hume; E Weyers
Journal:  J Clin Pathol       Date:  1972-06       Impact factor: 3.411

9.  Measurement of total body potassium with a shadow shield whole-body counter: calibration and errors.

Authors:  K Boddy; P C King; P Tothill; J A Strong
Journal:  Phys Med Biol       Date:  1971-04       Impact factor: 3.609

10.  changes in serum and urinary calcium during treatment with hydrochlorothiazide: studies on mechanisms.

Authors:  A S Brickman; S G Massry; J W Coburn
Journal:  J Clin Invest       Date:  1972-04       Impact factor: 14.808

View more
  9 in total

Review 1.  Angiotensin converting enzyme inhibitors for hypertension and heart failure?

Authors:  J G Cleland
Journal:  Postgrad Med J       Date:  1992-01       Impact factor: 2.401

Review 2.  Vascular tone in heart failure: the neuroendocrine-therapeutic interface.

Authors:  J G Cleland; C M Oakley
Journal:  Br Heart J       Date:  1991-10

Review 3.  Tissue and plasma angiotensin converting enzyme and the response to ACE inhibitor drugs.

Authors:  R J MacFadyen; K R Lees; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-01       Impact factor: 4.335

Review 4.  The place of ACE inhibitors in the current treatment of chronic heart failure.

Authors:  J McMurray; A D Struthers
Journal:  Postgrad Med J       Date:  1988-09       Impact factor: 2.401

5.  Mortality in heart failure: clinical variables of prognostic value.

Authors:  J G Cleland; H J Dargie; I Ford
Journal:  Br Heart J       Date:  1987-12

6.  Enalapril for severe heart failure in infancy.

Authors:  M Frenneaux; R A Stewart; C M Newman; K A Hallidie-Smith
Journal:  Arch Dis Child       Date:  1989-02       Impact factor: 3.791

Review 7.  Causes and treatment of oedema in patients with heart failure.

Authors:  Andrew L Clark; John G F Cleland
Journal:  Nat Rev Cardiol       Date:  2013-01-15       Impact factor: 32.419

8.  Acute and long-term renal and metabolic effects of piretanide in congestive cardiac failure.

Authors:  W R McNabb; F H Noormohamed; A F Lant
Journal:  Br J Clin Pharmacol       Date:  1988-08       Impact factor: 4.335

Review 9.  Acid-base and electrolyte abnormalities in heart failure: pathophysiology and implications.

Authors:  Caterina Urso; Salvatore Brucculeri; Gregorio Caimi
Journal:  Heart Fail Rev       Date:  2015-07       Impact factor: 4.214

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.